Categories: News

NYSE Content Advisory: Pre-Market Update + ICE to Invest up to $2 Billion in Polymarket

NEW YORK, Oct. 7, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on October 7th

- Advertisement -
  • Equities are little changed this morning after stocks kicked off the week in the green. The S&P 500 closed at another record high while the Russell 2000 also surged to a record.
  • Intercontinental Exchange (NYSE: ICE) has announced a strategic investment of up to $2 billion into prediction platform Polymarket. This will allow ICE to distribute Polymarket’s event-driven data to a global institutional audience for the first time.
  • ICE Chairman and CEO Jeff Sprecher said of the deal, “our investment blends ICE with a forward-thinking, revolutionary company pioneering change within decentralized finance. There are opportunities across markets which ICE together with Polymarket can uniquely serve.”
  • Canva is bringing its world tour to New York City. The design software company will be in Herald Square today as it aims to train a million new users on the platform in 30 days.


Opening Bell

The New York Rangers celebrate the start of the franchise’s Centennial Season

- Advertisement -


Closing Bell


Service Academy Women celebrates 50 years of enrollment at US Federal Service Academies

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2790481/NYSE_Market_Update_October_7.mp4

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–ice-to-invest-up-to-2-billion-in-polymarket-302577046.html

- Advertisement -

Recent Posts

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from…

32 minutes ago

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 4 February 2026 – Novo Nordisk A/S has filed its Annual Report 2025…

32 minutes ago

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

February 04, 2026 09:35 ET  | Source: Adial Pharmaceuticals, Inc GLEN ALLEN, Va., Feb. 04,…

32 minutes ago

Patton Acquires Practical Technologies Inc. (PTI) Creating Comprehensive Electronics Manufacturing Hub in Maryland

Patton®... Let's Connect! The liaison creates a powerful combination of manufacturing capabilities that significantly expands…

5 hours ago

ChipMOS Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call

February 04, 2026 05:00 ET  | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan, Feb. 04, 2026…

5 hours ago

Himax Industry-Leading OLED Touch IC Enters Mass Production for IT Applications Elevating the Integrated Display and Touch Experience

Industry-Leading Signal Processing and Algorithms Deliver Precise and Low Touch-Display Interference Across a Wide Range…

5 hours ago